Dr. Shu-fen Chen

Dr. Shu-fen Chen is a consultant neurologist at Chang Gung Memorial Hospital in Linkou, one of Asia's largest and most internationally recognised medical centres. Chang Gung Memorial Hospital is a JCI-accredited institution and consistently ranks among Asia's leading hospitals for neurological care, transplantation, and complex medicine. Dr. Chen heads the neuroimmunology and multiple sclerosis clinic within the Department of Neurology.

With over 22 years of neurological practice, Dr. Chen has developed particular expertise in the diagnosis and treatment of inflammatory neurological diseases including multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis, as well as stroke medicine and acute neurological emergencies. She leads a multidisciplinary MS care team and supervises the hospital's neurology residency training programme.

Dr. Chen trained at Chang Gung University and completed fellowship training in neuroimmunology at a leading North American academic centre. She is an active member of ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and regularly presents research at international neurology conferences. Taiwan's neurological care is internationally recognised for combining cutting-edge treatment with comprehensive patient support at highly competitive costs.

Dr. Chen graduated from Chang Gung University College of Medicine and completed her neurology residency at Chang Gung Memorial Hospital Linkou, one of Taiwan's premier neuroscience training environments. She then undertook a two-year fellowship in neuroimmunology and multiple sclerosis at a leading North American academic medical centre, gaining specialised expertise in MS disease-modifying therapy and autoimmune neurological conditions. She holds a PhD from Chang Gung University examining biomarkers in inflammatory CNS disease and is a Fellow of the American Academy of Neurology (FAAN).

Dr. Chen's clinical practice spans stroke medicine and neuroimmunology. In stroke care, she participates in the acute stroke team providing thrombolysis assessment and coordinating mechanical thrombectomy with interventional neuroradiology colleagues. Her primary subspecialty focus is multiple sclerosis and related demyelinating diseases including NMOSD and MOG antibody-associated disease, where she supervises initiation and monitoring of high-efficacy disease-modifying therapies including natalizumab, ocrelizumab, cladribine, and ofatumumab. She also manages autoimmune encephalitis, epilepsy associated with CNS inflammation, and headache disorders.

Dr. Chen has published over 35 peer-reviewed articles in journals including Multiple Sclerosis Journal, Neurology, and the Journal of Neuroimmunology. Her research focuses on the epidemiology of MS and NMOSD in East Asian populations, biomarker development for inflammatory CNS disease, and real-world effectiveness of disease-modifying therapies in the Taiwanese MS registry. She is a co-investigator in multinational clinical trials of novel MS therapeutics and serves on the editorial board of an international neurology journal.

Chang Gung Memorial Hospital's international medical centre facilitates care for patients from across Asia, the Middle East, and Southeast Asia seeking neurological evaluation and treatment. Dr. Chen is fluent in English and Mandarin Chinese, and her MS clinic is experienced in managing patients who travel internationally for second opinions or to access treatments not yet available in their home country. Video pre-consultation is available for review of imaging and case history prior to an in-person visit.

Dr. Chen has received the Taiwan Neurological Society's Young Investigator Award and the Chang Gung Medical Foundation Excellence in Research Award. She has been invited as a guest lecturer at the ECTRIMS Annual Meeting and the Asia-Pacific MS Forum, and serves on the Taiwan MS Society patient advisory committee.